Investigation Overview
July 1, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Revance Therapeutics Inc (NASDAQ:RVNC) was announced over potential breaches of fiduciary duties by certain officers and directors at Revance Therapeutics Inc. The investigation by a law firm concerns whether certain Revance Therapeutics Inc (NASDAQ:RVNC officers and direct...
You must register (for free) or login to view the entire investigation.